Stay informed on issues important to patients of Montgomery Cancer Center.
Montgomery Cancer Center among first in nation to treat advanced prostate cancer patients with Provenge
Montgomery Cancer Center is the first facility in Alabama and among the first in the nation to treat advanced prostate cancer patients with a promising new therapy. Read More
Thu, 24 Jul 2014 00:01:59 +0000
FDA Approves Beleodaq for Peripheral T-cell Lymphoma
The FDA announces its approval of Beleodaq (belinostat), a histone deacetylase inhibitor for treating peripheral T-cell lymphoma (PTCL), based on the results of the BELIEF study that found an overall response rate of nearly 26% among treated patients. PTCL accounts for about~15% of all non-Hodgkin’s lymphoma (NHL) cases in North America each year. Historically treatment […]read more
The most state-of-the-art technology of its kind in Alabama, TrueBeam™ from Varian Medical Systems integrates advanced imaging and motion management technologies to target tumors with sub-millimeter accuracy – and short treatment times.
Take a minute to visit the campus of Montgomery Cancer Center - without leaving your computer. Take a tour.
© Montgomery Cancer Center, 4145 Carmichael Road Montgomery, AL 36106